Operating Lease, Right-of-Use Asset of China SXT Pharmaceuticals, Inc. from 31 Mar 2023 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: China SXT Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2023 to 31 Mar 2025.
China SXT Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $176,648, a 25% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$176,648	-$59,200	-25%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q3 2024	$213,068			30 Sep 2024	6-K	28 Mar 2025	2025	Q2
Q1 2024	$235,848	-$70,202	-23%	31 Mar 2024	20-F	31 Jul 2025	2025	FY
Q1 2023	$306,050			31 Mar 2023	20-F	31 Jul 2023	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.